Neurotrophic factor signaling pathways modulate cellular and behavioral responses to drugs of abuse. In addition, chronic exposure to morphine increases expression of phospholipase C␥1 (PLC␥1) (a protein involved in neurotrophic signaling) in the ventral tegmental area (VTA), a neural substrate for many drugs of abuse. Using viral-mediated gene transfer to locally alter the activity of PLC␥1, we show that overexpression of PLC␥1 in rostral portions of the VTA (R-VTA) results in increased morphine place preference, whereas PLC␥1 overexpression in the caudal VTA (C-VTA) results in avoidance of morphine-paired compartments. In addition, overexpression of PLC␥1 in R-VTA causes increased preference for sucrose and increased anxiety-like behavior but does not affect responses to stress or nociceptive stimuli. In contrast, overexpression of PLC␥1 in C-VTA decreases preference for sucrose and increases sensitivity to stress and nociceptive stimuli, although there was a tendency for increased anxiety-like behavior as seen for the R-VTA. These results show that levels of PLC␥1 in the VTA regulate responsiveness to drugs of abuse, natural rewards, and aversive stimuli and point to the possibility that distinct topographical regions within the VTA mediate generally positive versus negative responses to emotional stimuli. Moreover, these data also support a role for drug-induced elevations in PLC␥1 expression in the VTA in mediating long-term adaptations to drugs of abuse and aversive stimuli.
Introduction
Neurotrophic factors and the signaling pathways they activate are best characterized for promoting growth, differentiation, and survival of neurons during development. More recently, these factors have been implicated as mediators of neuronal maintenance and plasticity in the adult nervous system (Barde, 1989; Lindsay et al., 1994; Patterson et al., 1996; Lu and Figurov, 1997) . Neurotrophic factor levels are altered during aging and in models of neurodegeneration and neuropsychiatric disorders, whereas intracranial infusions of neurotrophic factors can have palliative effects in these models (Gash et al., 1996; Nestler et al., 1996; Duman et al., 1997; Hellweg et al., 1998; Smith et al., 1999) .
The mesolimbic dopamine system, which consists of dopamine neurons in the ventral tegmental area (VTA) and their projections to the nucleus accumbens (NAc) (a major efferent region of the VTA) and other limbic regions, is a major substrate believed to regulate motivated behavior and responses to natural reinforcers such as food and sex (Di Chiara and North, 1992; Kelley and Berridge, 2002) . Drugs of abuse potently activate this pathway and, after repeated administration, cause long-term adaptations in VTA dopamine neurons and their targets (Wise, 1996; Koob et al., 1998; Nestler, 2001) . Among other adaptations, VTA dopamine neurons show increased levels of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis (Beitner-Johnson and Nestler, 1991; Sorg et al., 1993) , and they become smaller (Sklair-Tavron et al., 1996) and have diminished levels of neurofilament proteins and axoplasmic transport to the NAc (Beitner- Johnson et al., 1992; Beitner-Johnson and Nestler, 1993) .
Some of these biochemical and morphological adaptations of VTA dopamine neurons after chronic drug exposure are similar to changes seen in vitro and in vivo after neuronal injury or reduced neurotrophic support . Evidence for this premise comes from studies showing that infusion of certain neurotrophic factors into the VTA opposes the effects of drugs of abuse on these neurons (Berhow et al., 1995 Sklair-Tavron et al., 1996; Messer et al., 2000) . Moreover, chronic morphine exposure alters levels of specific neurotrophic factor-signaling proteins in this brain region (Ortiz et al., 1995; Berhow et al., 1996) , for example, phospholipase C␥1 (PLC␥1) (Wolf et al., 1999) . Of the known PLC isoforms, only PLC␥ is activated directly by neurotrophic factors (Rhee, 2001 ) and, of PLC␥ isoforms, only PLC␥1 is expressed in brain (Ross et al., 1989) . Unlike PLC␥, PLC␤ and PLC␦ are not regulated by morphine (Wolf et al., 1999) .
Despite the evidence that chronic morphine induces PLC␥1 in the VTA, the functional consequences of this effect have remained unknown. The present study was designed to address this question by examining the effect of increased PLC␥1 expression in this region, achieved with viral-mediated gene transfer, on behavioral responses to morphine and other emotional stimuli.
Materials and Methods
Animals. Male Sprague Dawley rats (Charles River, Kingston, NY), weighing 350 -375 gm at the start of the experiment, were used in this study. All animals were habituated to the animal facility for at least 1 week before experimental manipulation. Rats were double housed in clear polypropylene boxes containing wood shavings in an animal colony maintained at 23-25°C on a 12 hr light/dark cycle in which lights were on between 7:00 A.M. and 7:00 P.M. All animals were provided with food and water ad libitum. Experiments were conducted in accordance with guidelines of the Society for Neuroscience and the institutional animal review committee of The University of Texas Southwestern (Dallas, TX).
Viral vectors. cDNAs for PLC␥1 (obtained from S. G. Rhee, National Institutes of Health, Bethesda, MD) and LacZ were inserted into the herpes simplex virus (HSV) amplicon HSV-PrPUC and packaged into virus using the helper 5dl1.2, as described previously . The average titer of the recombinant virus stocks was 4.0 ϫ 10 7 infectious units/ml. Titers did not differ by Ͼ10% among preparations. All behavioral experiments were commenced on day 3 after viral surgery, a time at which maximal transgene expression caused by these vectors was observed (Carlezon et al., 1998) . Expression of the HSV-encoded transgenes is limited to an area of ϳ1 mm 3 around the injection site, and no expression is seen in either efferent or afferent regions of the injected area. Thus, we found no detectable PLC␥1 or LacZ expression in either the NAc or the dorsal raphe (a major afferent region of the VTA).
Animal surgery. For viral injections in rats, animals were anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and given atropine (0.25 mg/kg, s.c.) to minimize bronchial secretions. Afterward, animals were given unilateral microinjections (2.0 l over 10 min) of either HSV-PLC␥1 or HSV-LacZ (used as a control) into rostral VTA (R-VTA) (anteroposterior, Ϫ4.9; lateral, ϩ2.2; dorsoventral, Ϫ7.6 mm below dura) (see Fig. 1 A) or caudal VTA (C-VTA) (anteroposterior, Ϫ6.0; lateral, ϩ2.2; dorsoventral, 7.6 mm below dura) (see Fig. 1 B) (Paxinos and Watson, 1997 ) using a 32 gauge Hamilton syringe angled at 10°from the midline to avoid piercing the sinus system. All needle placements ranging from Ϫ4.9 to Ϫ5.5 mm from bregma were considered R-VTA, whereas placements ranging from Ϫ5.5 to Ϫ6.3 mm were considered C-VTA.
Conditioned place preference. Place conditioning was performed exactly as described previously (Carlezon et al., 1997) . Briefly, place preference conditioning to morphine sulfate (concentration expressed as base) was performed in a three-compartment apparatus (Med Associates, St. Albans, VT). Before viral injections (day 0), rats were allowed to freely explore the entire apparatus for 30 min to obtain baseline preference to any of the three compartments. Only rats showing no spontaneous preference to either compartment were used (unbiased procedure), which accounted for Ͼ80% of all of the animals tested. Rats then received unilateral injections of HSV-PLC␥1, HSV-LacZ, or sham surgery (lowered needle to targeted brain site but no volume injection) into the R-VTA or C-VTA and were allowed to recover for 2 d. After recovery, conditioning trials (two per day) were given on 2 consecutive days (days 3 and 4). On the first conditioning trial, rats received saline (1.0 mg/kg, s.c.) and were confined to one of the large-sized compartments of the apparatus. After 3 hr, rats received morphine (0.125, 0.25, or 0.50 mg/kg, s.c.; National Institute on Drug Abuse, Bethesda, MD) and were confined to the opposite-side compartment. On the final day (day 5), rats were again allowed to freely explore the entire apparatus for 30 min.
Sucrose preference. The sucrose preference test consisted of a twobottle choice paradigm, performed under red light at the beginning of the dark phase. At the start of the experiment, rats were habituated to drink a 1% sucrose solution for 3 d. On day 4, the sucrose solution was replaced with tap water for an additional 2 d. Two hours (5:00 P.M.) before the test (at the end of day 5), rats were singly housed with access to food. At the start of the dark phase (7:00 P.M.), rats were given access to the two bottles (containing water or 1% sucrose). The position of the sucrose bottle (left or right) was balanced between the experimental groups. Fluid intake was then measured for 30 min. At the end of the testing period, rats were again housed in pairs. The total amount of fluid (water or sucrose) intake was considered baseline preference. Only rats showing a Յ60% preference to sucrose over water were used for the rest of the experiment. Four days after the pretest (i.e., baseline preference), animals received intracranial HSV or sham microinjections into R-VTA or C-VTA. On day 3 after surgery, the sucrose preference test was repeated exactly as performed on day 5 of baseline.
Forced swim test. The forced swim test is a 2 d procedure in which rats are forced to swim under conditions in which they cannot escape. On the first day, rats are forced to swim. Initially, they engage in a variety of escape-like behaviors, but they eventually adopt a posture of immobility in which they make only the movements necessary to maintain their head above water. When retested 24 hr later, rats become immobile more quickly. However, antidepressant treatment between the forced swim exposures can significantly increase their escape-like behaviors, an effect that has been correlated with antidepressant activity in humans (Porsolt et al., 1977; Cryan et al., 2002) . Rats received HSV-PLC␥1, HSV-LacZ, or sham surgery injections into R-VTA or C-VTA as described above. On day 3 after surgery, rats were placed in plastic cylinders (30 ϫ 45 cm) filled to 30 cm depth (so that the paws and tail do not touch the bottom) with 25°C water and forced to swim for 15 min. At the end of this period, rats were removed from the water, dried with towels, and kept in a warm enclosure for 30 min. All cylinders were emptied and cleaned between rats. Twenty-four hours after the forced swim, rats were retested for 5 min under identical conditions, and sessions were videotaped by a camera attached to the ceiling of the testing room. Raters unaware of the treatment conditions scored the videotapes. In this study, the latency to become immobile was the dependent variable. Latency to immobility was defined as the time at which the rat first initiated a stationary posture that did not reflect attempts to escape from the water (Lucki, 1997; Pliakas et al., 2001) . To qualify as immobility, this posture had to be clearly visible and maintained for Ն2.0 sec.
Locomotor activity. A separate group of rats was used to examine whether gene transfer treatments affected general locomotor activity 24 hr after day 1 of forced swimming. Rats received HSV microinjections or sham surgery into R-VTA or C-VTA and were placed for 1 hr in automated (75 cm diameter ϫ 15 cm wide, four photocell beams) circular activity chambers (Med Associates).
Response to nociceptive stimuli. In this test, we exposed rats to an electric foot-shock session in an apparatus consisting of a computerized box with a grid floor . The threshold of foot-shock intensity required to induce a behavioral response was determined. After 2 min of habituation to the testing chamber, rats received a foot shock every 30 sec starting at 0.05 mA, with a 0.05 mA increment between each shock (to a maximum of 1.0 mA). The first appearance of a flinch, an audible vocalization, and a jump were recorded. The test session was terminated after all three behavioral responses were observed in each animal.
Elevated-plus maze. Rats receiving HSV microinjections or sham surgery into R-VTA or C-VTA were tested for 5 min on the elevated-plus maze, a behavioral test of anxiety-like behavior. The maze was made of gray plastic and consisted of two perpendicular, intersecting runways (12 cm wide ϫ 100 cm long) . One runway had tall walls (40-cm-high "closed arms"), whereas the other one had no walls ("open arms"). The arms were connected by a central area, and the maze was elevated 1 m from the floor. Testing was conducted between 9:00 A.M. and 1:00 P.M. under controlled light conditions (ϳ90 lux). At the begin-ning of the 5 min observation, animals were placed in the central area facing one of the open arms, and the cumulative time spent in the open arms was videotaped by a camera placed on the ceiling of the testing room. Raters unaware of the treatment conditions scored the videotapes.
Histology. At the end of the behavioral experiments, rats were anesthetized with an overdose of chloral hydrate and were perfused transcardially with 0.9% saline, followed by cold 4% paraformaldehyde. The brains were removed, postfixed overnight in 4% paraformaldehyde, and stored in 20% glycerol solution. Coronal sections (45 m) through the midbrain were taken on a microtome and stored in 0.1 M sodium phosphate buffer with 0.05% azide. Sections were processed for verification of injection placements or transgene expression using immunohistochemistry as described below. Data obtained from rats with placements outside the intended brain regions (Ͻ10% of all experimental animals) were not included in the analyses.
Transgene detection. Immunohistochemical staining was used to examine the ability of the HSV constructs to drive expression of PLC␥1 and LacZ [␤-galactosidase (␤-gal)] within the VTA. Midbrain free-floating coronal sections were processed for immunohistochemistry using the following antibodies: PLC␥1 (1:2000 mixed mouse monoclonal; Upstate Biotechnology, Lake Placid, NY); ␤-galactosidase (1:5000 goat polyclonal; Biogenesis, Poole, UK); or TH (1:5000, rabbit polyclonal; Chemicon, Temecula, CA). Adjacent sections were blocked in 3% normal donkey serum (NDS) and incubated overnight in one of the primary antibodies mentioned above, along with 0.3% Triton X-100 (Fisher Scientific, Pittsburgh, PA) and 1% NDS. Sections were incubated with the appropriate biotinylated anti-goat, anti-mouse, or anti-rabbit secondary antibody (1:200; Jackson ImmunoResearch, West Grove, PA) for 2 hr at room temperature. Stained sections were then slide mounted (Fisher Scientific), dehydrated in ethanol and citrosolv, and coverslipped with clear DPX adhesive (Sigma, St. Louis, MO). Slides were then visualized and photographed using a fluorescence microscope and a digital camera.
Statistical analysis. Significance was measured using one-way and two-way ANOVAs. When appropriate, Student's t test and F test were used to determine statistical significance of preplanned comparisons involving two groups. Data are expressed as the mean Ϯ SEM. Statistical significance was defined as p Ͻ 0.05. Figure 1 , A and B, shows the R-VTA and C-VTA to which microinjections of HSV vectors (HSV-LacZ or HSV-PLC␥1) were aimed, and Figure 2 shows the range of injected rostral and caudal regions targeted in a typical experiment. We separately targeted rostral and caudal subregions of the VTA on the basis of previous evidence that manipulation of the two regions can differentially regulate morphine reward (Carlezon et al., 2000b) . As reported previously for HSV-LacZ and several other HSV vectors (Carlezon et al., 1997 (Carlezon et al., , 1998 (Carlezon et al., , 2000b Barrot et al., 2002) , we found that expression of LacZ (Fig. 1C) and PLC␥1 (Fig. 1 D) was maximal between days 3 and 4 after virus injection, and it significantly declined thereafter as a result of the transient nature of transgene expression . Viralmediated expression was restricted to an area of the VTA of ϳ1 mm in diameter and was accompanied by minimal damage (Fig. 1 E) that was indistinguishable from that caused by microinjection of vehicle alone (10% sucrose). No change in PLC␥1 immunoreactivity was present in rats given HSV-LacZ microinjections, confirming that increased PLC␥1 expression in HSV-PLC␥1-treated animals is not a nonspecific reaction to surgery or viral infection (Fig. 1 F-H ) . Confocal microscopy ( Fig. 1 I-K ) revealed that 52% of the neurons overexpressing PLC␥1 in R-VTA were dopaminergic (i.e., TH positive), whereas in C-VTA, 65% of the PLC␥1-infected neurons were double labeled. This difference, which is similar to previous findings (Carlezon et al., 2000b) , did not reach statistical significance ( p Ͼ 0.1). As found in previous studies using HSV vectors, we found no detectable expression of the viral-encoded transgenes in glial cells (data not shown).
Results

Viral-mediated gene transfer in the VTA
PLC␥1 regulation of morphine-conditioned place preference
Conditioned place preference has been widely used to assess the rewarding or aversive properties of drugs. In this behavioral assay, animals learn to prefer environments associated previously with rewarding drug effects, while they avoid environments associated with aversive drug effects (Hoffman, 1989) . As seen in Figure 3A , time spent in the morphine-paired compartment varied as a function of viral vector treatment and VTA region (viral treatment ϫ region interaction, F (2,107) ϭ 9.2; p Ͻ 0.0002). Animals receiving HSV-PLC␥1 injections into the R-VTA spent significantly more time in environments paired with threshold doses of morphine [0.25 ( p ϭ 0.06) and 0.50 ( p ϭ 0.04) mg/kg], whereas rats with PLC␥1 microinjections into the C-VTA did not consistently approach the morphine-paired environments when compared with their HSV-LacZ or sham controls. In fact, microinjecting HSV-PLC␥1 into the C-VTA resulted in avoidance of the morphine-paired compartments [0.25 ( p ϭ 0.001) and 0.50 ( p ϭ 0.0001)]. Both the increased reward seen with PLC␥1 overexpression in R-VTA and the aversion seen with PLC␥1 overexpression in C-VTA showed a clear dose response. In contrast, microinjections of HSV-PLC␥1 into the nearby substantia nigra did not make these doses of morphine rewarding or aversive (data not shown).
PLC␥1 regulation of sucrose preference
To generalize the place-conditioning effects of PLC␥1 in the VTA to a natural reward, and to a behavioral paradigm free of associative memory, we studied sucrose preference. Overall analysis indicated that HSV microinjections did not significantly affect the total fluid intake of the rats (water plus sucrose) (Fig. 3B) during the testing day. However, similar to the effects seen with morphine place conditioning, sucrose preference varied as a function of VTA region, viral treatment, and testing (viral treatment ϫ region ϫ test day interaction, F (2,106) ϭ 3.7; p Ͻ 0.02). PLC␥1 overexpression in R-VTA increased sucrose preference when compared with pretesting scores ( p Ͻ 0.003) and with the LacZ ( p Ͻ 0.05) and sham ( p Ͻ 0.05) control groups during the test day (Fig. 3B) . Conversely, PLC␥1 overexpression in C-VTA showed a notable, although marginally significant ( p ϭ 0.065), decrease in sucrose preference when compared with their sucrose scores at pretest and a significant difference when compared with preference scores for the HSV-LacZ ( p Ͻ 0.05) or sham ( p Ͻ 0.05) groups. As an additional control, we found that HSV-PLC␥1 microinjections into the substantia nigra did not affect sucrose preference (data not shown).
PLC␥1 regulation of forced swimming
Given the increasing evidence that the mesolimbic dopamine system regulates responses to aversive stimuli as well as rewarding ones , it was of interest to study the effect of PLC␥1 overexpression in behavioral tests of aversion. We first used the forced swim test to study animal responses to stressful conditions (Pliakas et al., 2001; Cryan et al., 2002) . In this test, animals initially struggle trying to escape, but within 1 or 2 min, they become immobile. The amount of time rats engaged in escape-directed behaviors (i.e., latency to immobility) in the forced swim test was dependent on viral treatment. Animals receiving HSV-PLC␥1 into the C-VTA had significantly shorter times to become immobile (treatment main effect, F (2,13) ϭ 5.2; p Ͻ 0.02) than rats receiving sham ( p Ͻ 0.014) or HSV-LacZ ( p Ͻ 0.017) microinjections into the C-VTA (Fig. 4 A) . In contrast, no difference in the latency to immobility was apparent in animals receiving HSV-PLC␥1 into the R-VTA. To assess whether the effects observed in the forced swim test could be confounded by changes in general locomotor activity after viralmediated gene transfer, separate groups of HSV-PLC␥1, HSVLacZ, or sham surgery animals were analyzed for locomotor behavior. As seen in Figure 4 B, no significant differences were apparent during PLC␥1 overexpression in either the C-VTA or R-VTA (F (2,24) ϭ 1.6; p Ͼ 0.2), when locomotor activity was assessed 24 hr after day 1 of forced swimming (day 4 after HSV microinjections). HSV-PLC␥1 microinjections into the substantia nigra did not alter the responses of the animals in the forced swim test (data not shown).
PLC␥1 regulation of responses to nociceptive stimuli
Our findings thus far show that PLC␥1 overexpression in the R-VTA and C-VTA can differentially modulate behavioral responses to rewarding and stressful stimuli. We next assessed the influence of PLC␥1 overexpression in the VTA on unconditioned behavioral responses to nociceptive stimuli. When compared with control groups, overexpression of PLC␥1 in the C-VTA decreased the threshold foot-shock intensities required to elicit vocalization (F (1,42) ϭ 6.37; p Ͻ 0.05) or jumping (F (1,42) ϭ 8.43; p Ͻ 0.001) without significantly affecting the threshold intensity eliciting a flinch reaction (Fig. 5A ). These data suggest that animals receiving HSV-PLC␥1 into the C-VTA are more sensitive to this mild nociceptive stimulus. In contrast, animals receiving HS-V-PLC␥1 into the R-VTA showed no difference in nociceptive responses (Fig. 5A ).
PLC␥1 regulation of elevated-plus maze behavior
We also studied the effect of PLC␥1 overexpression in the R-VTA and C-VTA on anxiety-like behavior using the elevated-plus maze. Time spent in the open arms of the plus maze (a measure of anxiety-like behavior) was affected by viral treatment (condition main effect, F (2,36) ϭ 8.51; p Ͻ 0.0009), but it did not vary as a function of VTA region (Fig. 5B) . Animals receiving HSV-PLC␥1 in R-VTA spent significantly less time in the open arms of the maze than the HSV-LacZ ( p ϭ 0.01) and sham ( p ϭ 0.005) controls, an indication of increased anxiety-like behavior. However, there was a trend for a similar decrease in time spent on the open arms in rats microinjected with HSV-PLC␥1 in C-VTA compared with the HSV-LacZ or sham controls ( p ϭ 0.065 in each case).
Discussion
Previous reports have implicated neurotrophic factors in the cellular and behavioral adaptations occurring in the VTA after prolonged exposure to drugs of abuse (see Introduction). Moreover, chronic exposure to drugs of abuse has been shown to alter several components of neurotrophic factor-signaling cascades within this brain region. One example was our demonstration that repeated exposure to morphine increases levels of PLC␥1 in the VTA (Wolf et al., 1999) . Although PLC␥1 has been implicated in mediating several neurobiological processes (Kamat and Carpenter, 1997; Rhee, 2001) , the functional role this signaling protein plays in mediating responses to drugs of abuse has remained unknown. Thus, in the present study, we mimicked the biological response of PLC␥1 induction observed after chronic morphine by using viral-mediated gene transfer to locally increase PLC␥1 levels in the VTA. We showed that increased expression of PLC␥1 in the VTA modulates behavioral responses to morphine and to sucrose (a natural reward), as well as several aversive stimuli. In Figure 3 . PLC␥1 regulates responses to rewarding stimuli. A, Morphine (0.125, 0.25, and 0.50 mg/kg, s.c.) place conditioning. PLC␥1 overexpression in R-VTA enhanced sensitivity to threshold doses of morphine, whereas overexpression of this protein in C-VTA resulted in place aversion. Sham surgery and ␤-gal expression (via HSV-LacZ) had no effect on place conditioning. *p Ͻ 0.05; †p ϭ 0.06. B, Sucrose preference. Sham surgery and ␤-gal expression did not affect sucrose preference, regardless of VTA region. PLC␥1 overexpression in R-VTA significantly Figure 4 . PLC␥1 regulates responses to swim stress. A, Latencies to become immobile varied as a function of viral vector treatment and VTA region. Latencies were significantly decreased in rats treated with HSV-PLC␥1 in C-VTA. HSV-LacZ or sham injections had no effect. Data are presented as latencies (mean Ϯ SEM, in seconds) during the 5 min test on day 4 after HSV microinjections. B, There were no group differences when activity, rather than swimming, was quantified during testing day. *p Ͻ 0.002. Error bars indicate SEM. 4 increased sucrose preference, whereas PLC␥1 in C-VTA decreased sucrose preference, respectively. Data are presented as percentage difference of total liquid intake between pretest and posttest (top) or as difference in liquid intake between sucrose and water bottle (bottom). PLC␥1 overexpression did not affect total fluid (sucrose plus water) intake (bottom). *p Ͻ 0.05; †p ϭ 0.065. Error bars indicate SEM.
addition, we showed that regulation of these behavioral responses elicited by emotional stimuli is dependent on the subregion of the VTA in which PLC␥1 is overexpressed. Our findings describe two distinct behavioral phenotypes caused by PLC␥1 overexpression in the rostral versus caudal aspects of the VTA. In the R-VTA, increased levels of PLC␥1 increase the sensitivity of an animal to the rewarding effects of morphine as well as the sucrose preference of an animal, while causing little change in its responses to aversive stimuli. In contrast, in the C-VTA, increased levels of PLC␥1 cause the opposite effects on reward, with reduced responses to morphine and sucrose observed, but also induce greater sensitivity to several types of aversive stimuli, including swim stress and nociceptive and anxiogenic challenges. These data thereby suggest two distinct functional loops mediated by drug-induced upregulation of PLC␥1 expression in rostral and caudal subregions of the VTA. In the R-VTA, upregulation of PLC␥1 would appear to mediate a state of sensitized responses to drug and natural rewards. In contrast, in the C-VTA, upregulation of PLC␥1 would appear to mediate a depressed emotional state characterized by reduced sensitivity to reward and enhanced sensitivity to negative emotional stimuli.
The opposite effects of PLC␥1 overexpression in R-VTA versus C-VTA on measures of drug reward are in agreement with several previous studies that have demonstrated that topographical differences within the VTA mediate the rewarding and aversive properties of drugs (Ikemoto et al., 1997 (Ikemoto et al., , 1998 Carlezon et al., 2000b; Olson et al., 2001 ), and we now extend these previous findings to a natural reward, namely sucrose. Although the mechanism(s) underlying these topographical differences remain unknown, two explanations have been offered. The first speculates that distinct populations of dopamine neurons within the VTA might mediate the divergent behavioral effects observed between R-VTA and C-VTA. Neuroanatomical studies indicate that dopamine neurons from more rostral portions of the VTA innervate primarily, but not exclusively, the NAc shell, whereas dopamine neurons from C-VTA project predominantly, but not exclusively, to cortical areas (Emson and Koob, 1978; Brog et al., 1993) . Moreover, these projections show differential regulation by morphine: morphine increases extracellular dopamine levels in the NAc shell but has no effect in prefrontal cortical areas (Bassareo et al., 1996) , whereas morphine withdrawal is associated with decreased extracellular dopamine levels in the NAc shell but increased levels in prefrontal cortex (Acquas et al., 1991; Pothos et al., 1991; Bassareo et al., 1995) . Thus, within this framework, it is conceivable that increased PLC␥1 activity in R-VTA dopamine neurons enhances reward to morphine and sucrose while resulting in opposite effects when PLC␥1 activity is enhanced in C-VTA dopamine neurons.
The second explanation focuses on distinct populations of nondopaminergic, most likely GABAergic, neurons in the R-VTA versus C-VTA, which differentially regulate drug and sucrose reward. GABAergic neurons in the VTA have long been known to regulate the activity of VTA dopamine neurons (Di Chiara and North, 1992; Johnson and North, 1992) and, more recently, have been shown to project directly to the NAc (Van Bockstaele and Pickel, 1995; Steffensen et al., 1998) , thereby providing two mechanisms by which these neurons control activity of the mesolimbic reward pathway. GABAergic activity in the VTA has been shown to play an increasingly important role in modulating the behavioral and cellular responses to rewarding (Roberts and Brebner, 2000; Laviolette and van der Kooy, 2001; Steffensen et al., 2001 ) and aversive (Bonci and Williams, 1997; Chieng and Williams, 1998) stimuli. The HSV vectors used in this study are not selective for a particular type of neuron Carlezon et al., 2000a) , and appear to infect all neuronal types within a given brain region with approximately equal efficiency. However, because the density of dopaminergic neurons in the VTA decreases from caudal to rostral subregions, it is possible that PLC-␥1 overexpression may occur to a greater extent in nondopaminergic cells in the R-VTA compared with the C-VTA. Indeed, whereas a clear majority of HSV-infected cells in the C-VTA are dopaminergic (i.e., TH positive), a somewhat smaller percentage of infected cells in the R-VTA are dopaminergic. However, additional work is needed to determine whether this difference in PLC-␥1 overexpression in dopaminergic versus nondopaminergic cells between R-VTA and C-VTA can explain the differential behavioral effects observed. In addition, it will be important in future investigations to determine whether the morphine-induced upregulation of PLC␥1 occurs predominantly in dopaminergic, nondopaminergic, or both cell types in the VTA. GABAergic neurons are a likely candidate for the nondopaminergic cells involved in this phenomenon. Unfortunately, it has not been possible to directly identify cell bodies of these neurons in the VTA because of limitations in available antibodies.
Our findings that PLC␥1 overexpression in the C-VTA alters the sensitivity of an animal to aversive stimuli lends additional support to the notion that the mesolimbic reward pathway may play a role in the symptoms of depression and other stress-related syndromes (Kapur and Mann, 1992; Naranjo et al., 2001; Pliakas et al., 2001; Yadid et al., 2001; Nestler et al., 2002) . Thus, animals that received HSV-PLC␥1 injections in the C-VTA exhibited shorter latency to immobility in the forced swim test, an effect opposite to that of antidepressant treatments (Cryan et al., 2002) . In contrast, microinjections of HSV-PLC␥1 into R-VTA had no effect in this assay. The decreased latency to immobility obtained with HSV-PLC␥1 injections in the C-VTA was not caused by changes in general motor activity, which was unaffected by PLC␥1 overexpression. Additionally, sham treatment or injection of HSV-LacZ into the C-VTA did not affect latency to immobility, indicating that surgery or viral infection per se does not affect forced swimming. Additional studies with foot-shock stress and the elevated-plus maze found that PLC␥1 overexpression in the C-VTA increased the responses of the animals to nociceptive and anxiogenic stimuli. Thus, the induction of PLC␥1 in C-VTA, by decreasing responses to rewarding stimuli while increasing responses to aversive stimuli, could contribute to a similar constellation of symptoms, which are seen in many drug addicts, particularly during early phases of drug withdrawal (Gawin and Kleber, 1986; Gawin et al., 1989; Barr et al., 2002) . It also would be interesting to investigate the possible involvement of PLC␥1 in the C-VTA now in mediating these and certain other symptoms of depression (American Psychiatric Association, 1994) .
To summarize, results of the present study establish the functional importance of morphine-induced upregulation of PLC␥1 expression in the VTA. Our findings define two distinct feedback loops whereby PLC␥1 induction in R-VTA versus C-VTA mediate distinct behavioral adaptations to chronic morphine exposure. Additional understanding of the mechanisms underlying this PLC␥1-induced behavioral plasticity will lead to a better understanding of the neural and molecular basis of drug addiction.
